IRIS Institutional Research Information System - OPENBS Open Archive UniBS

AVENOSO, Daniele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 236
EU - Europa 83
NA - Nord America 63
SA - Sud America 1
Totale 383
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 126
HK - Hong Kong 76
US - Stati Uniti d'America 63
RU - Federazione Russa 30
TR - Turchia 30
IT - Italia 22
FI - Finlandia 17
DE - Germania 9
CN - Cina 2
FR - Francia 2
BE - Belgio 1
BR - Brasile 1
CH - Svizzera 1
IL - Israele 1
IN - India 1
PT - Portogallo 1
Totale 383
Salva come PNG Salva come JPEG
Città #
Singapore 85
Hong Kong 76
Istanbul 30
Des Moines 22
Moscow 21
Helsinki 17
Falkenstein 4
Frankfurt am Main 3
Milan 3
Rome 3
Ancona 2
Brescia 2
Sommacampagna 2
Ashburn 1
Aubonne 1
Beijing 1
Brussels 1
Holon 1
New York 1
Pavia 1
Pune 1
Romola 1
Tanque Novo 1
The Dalles 1
Totale 281
Salva come PNG Salva come JPEG
Nome #
Haploientical Transplants with Post-Transplant Cyclophosphamide for Relapsed or Refractory Hodgkin Lymphoma: The Role of Comorbidity Index and Pretransplant Positron Emission Tomography 17
ECP versus ruxolitinib in steroid-refractory acute GVHD - a retrospective study by the EBMT transplant complications working party 16
CMV Colitis: A Rare Complication of Azacitidine and Venetoclax Chemotherapy 16
Epigenetic Regulation in Myelodysplastic Syndrome as A Consequence of A MicroRNA Dysregulation 15
Lymphoid blast crisis after prolonged treatment‐free remission in chronic myeloid leukaemia after tyrosine kinase inhibitor de‐escalation during the COVID‐19 pandemic 14
Modern views of nutritional support in patients undergoing allogeneic stem cell transplantation 14
De novo AML patients with favourable-intermediate karyotype may benefit from the addition of low-dose gemtuzumab ozogamicin (GO) to fludarabine, Ara-C and idarubicin (FLAI): a contribution to the reopened "GO question" 14
ECP versus ruxolitinib in steroid-refractory chronic GVHD – a retrospective study by the EBMT transplant complications working party 14
A Cellular Therapy with Haploidentical Peripheral Hematopoietic Stem Cell Transplantation MAY be a Therapeutic Option in Patients with Relapsed Lymphoma with Chemorefractory Disease 13
Adoptive Immunotherapy via Donor Lymphocyte Infusions following Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis: A Real-World, Retrospective Multicenter Study 13
Impact of HLA Disparity in Haploidentical Bone Marrow Transplantation Followed by High-Dose Cyclophosphamide 13
Isolated Cerebral Myeloid Sarcoma in an Allogeneic Stem Cell Transplant Recipient 13
Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT 13
Case report – Prolonged SARS-CoV-2 positive PCR after resolution of symptoms 13
Outcomes after allogeneic hematopoietic cell transplant in patients diagnosed with blast phase of myeloproliferative neoplasms: A retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation 12
Microbial Contamination of Haematopoietic Stem Cell Products: A Single Centre Experience 12
Early and late-onset veno-occlusive disease/sinusoidal syndrome post allogeneic stem cell transplantation - a real-world UK experience 12
Post-transplant cyclophosphamide in acute leukemia patients receiving more than 5/10 HLA-mismatched allogeneic hematopoietic cell transplantation from related donors: A study on behalf of the ALWP of the EBMT 12
Haploidentical Transplant with Post-Transplant Cyclophosphamide for Acute Myeloid Leukaemia and Myelodysplastic Syndromes Patients: The Role of Previous Lines of Therapy 12
Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMT 12
Human parainfluenza virus type 3 infections in a haemato-oncology unit: social distancing measures needed in outpatient clinics 11
Myeloablative dose of busulfan and fludarabine combined with in vivo T-cell depletion is a safe and effective conditioning for acute myeloid leukaemia and myelodysplastic syndrome patients 11
Next Generation Sequencing and Microrna Assay in a Cohort of Patients Affected By Myelodysplastic Syndromes. an Analysis of Clinical and Genotypic Features 10
Hepatosplenic T-cell lymphoma with aberrant expression of serum β-HCG: A case report 10
Neuro-toxoplasmosis in haploidentical haematopoietic stem cell transplant 10
Is the New Tci Score Sufficient to Categorize the Intensity of Conditioning? a Single-Centre Study 9
Systematic screening and focused evaluation for venous occlusive disease/sinusoidal obstructive syndrome (VOD/SOS) following allogeneic stem cell transplant is associated with earlier diagnosis and prompt institution of defibrotide treatment 9
SARS-CoV-2 infection in aplastic anemia 9
Fludarabine-Melphalan-Campath, Followed by Unmanipulated Peripheral-Blood Haematopoietic Stem Cells, Can Still Cure Lymphoma 9
Second allogeneic haematopoietic stem cell transplant conditioned with treosulfan and fludarabine is associated with encouraging overall survival and transplant related mortality in late relapse of myeloid malignancies 9
Thymoma and pure red cell aplasia with hypoplasia of megakaryocytopoiesis: A rare and life-treating condition 8
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease 8
Unusual CD34 positivity in acute myeloid leukaemia with myelodysplasia‐related changes with megakaryoblastic differentiation 8
Thymoma and pure red cell aplasia with hypoplasia of megakaryocytopoiesis: A rare and life-treating condition 8
Repeated vaccination against SARS-CoV-2 elicits robust polyfunctional T cell response in allogeneic stem cell transplantation recipients 8
Real-world collection of secondary myeloid neoplasms after CD19 CAR-T cell therapy: first report of the ClonHema study 7
Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience 6
Totale 420
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.244
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.244
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20231 0 0 0 0 0 0 0 1 0 0 0 0
2023/20244 0 0 0 0 0 1 0 0 2 0 0 1
2024/2025415 0 0 35 92 66 55 89 11 49 18 0 0
Totale 420